Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL27628652

CC(C)(C)OC=O.O=C1CCN(S(=O)(=O)C23CCN(Cc4ccccc4)C2C3)CC1

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP2C19 P33261 1/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPT P10636 1/20 0.31
SIGMAR1 Q99720 4/20 0.31
NR3C1 P04150 3/20 0.31
PKM P14618 1/20 0.31
NPY1R P25929 1/20 0.30
HTT P42858 1/20 0.30
NPY2R P49146 1/20 0.30
TMEM97 Q5BJF2 1/20 0.30
CYP3A4 P08684 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL28307746 0.73 SIGMAR1 (0.47) MEN1KMT2ASIGMAR1
SCHEMBL12971547 0.66 CYP2D6 (0.50) CYP2D6MEN1KMT2ACYP2C19ALDH1A1
Tert-Butyl Formate SCHEMBL28780380 0.64 GPR119 (0.42) MEN1KMT2AALDH1A1MAPTSIGMAR1
Tert-Butyl Formate SCHEMBL27994114 0.63 CYP2C19 (0.43) CYP2C19MAPTSIGMAR1
SCHEMBL222005 0.61 CYP2D6 (0.49) CYP2D6MEN1KMT2ACYP2C19ALDH1A1
Tert-Butyl Formate SCHEMBL28284769 0.61 TDP1 (0.48)
Tert-Butyl Formate SCHEMBL27524789 0.61 SIGMAR1 (0.66) MEN1KMT2ACYP2C19ALDH1A1SIGMAR1
SCHEMBL23085847 0.61 STS (0.44) KMT2APKM
Tert-Butyl Formate SCHEMBL28750430 0.60 TDP1 (0.50) ALDH1A1
SCHEMBL14034000 0.59 PARP1 (0.39) CYP2C19ALDH1A1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1812814-A Dispersible pharmaceutical composition for treatment of mastitis and otic disorders PHARMACIA & UPJOHN CO LLC (US) 2006-08-02 CN claimed
CN-1812814-A Dispersible pharmaceutical composition for treatment of mastitis and otic disorders PHARMACIA & UPJOHN CO LLC (US) 2006-08-02 CN disclosed